エレクトロシューティカルズ・バイオエレクトリック医療の世界市場規模：製品タイプ別、用途別、エンドユーザー別、地域別、範囲および予測

エレクトロシューティカルズ・バイオエレクトリック医療の市場規模と予測

エレクトロシューティカルズ・バイオエレクトリック医療の市場規模は、2024年に193億8,000万米ドルと評価され、2024年から2031年にかけてCAGR 4.5%で成長し、2031年には275億6,000万米ドルに達すると予測されています。電気治療薬（生体電気医療）は、電気インパルスを使って体内の神経回路を調節し、病気を治療する医療機器です。特定の神経や組織をターゲットとし、神経系の電気信号を変化させることで生理機能を回復させたり、症状を緩和させたりします。電気治療薬は、さまざまな医療分野で多様な応用がなされています。一般的には、慢性疼痛、神経疾患、糖尿病などの代謝性疾患の治療に用いられます。例えば、植え込み型神経刺激装置は、脳への疼痛信号を遮断することで、慢性疼痛の管理に用いることができます。

神経学では、脳深部刺激（DBS）が、異常な脳活動を調節することによってパーキンソン病のような運動障害を治療するために採用されています。

さらに、電気製剤は、心臓のリズムを調整する心臓ペーシングや、糖尿病管理におけるインスリン分泌を制御するバイオエレクトロニック・インプラントなどの応用に有望視されています。

電気製剤の将来は、革新と拡大の大きな可能性を秘めています。小型化、無線技術、生体適合性材料の進歩は、電気製剤デバイスの有効性と安全性を高めています。研究者たちは、精神疾患、自己免疫疾患、胃腸疾患などの分野での新たな応用を模索しています。

エレクトロシューティカルズ・バイオエレクトリック医療の世界市場力学

世界のエレクトロシューティカルズ・バイオエレクトリック医療市場を形成している主な市場力学

主な市場促進要因

非薬物療法に対する需要の増加：

薬物の副作用や依存性に対する懸念から、患者やヘルスケア提供者の間で非薬理学的治療に対する嗜好が高まっています。電気治療薬は、慢性疼痛、神経障害、心血管疾患などの病態を効果的に管理できる、的を絞った精密な治療法を提供します。NIHの一部門であるNational Center for Complementary and Integrative Health（NCCIH）によると、非薬理学的疼痛管理技術の使用は2020年から2023年の間に25%増加しました。

技術の進歩：

エレクトロニクス、材料科学、神経刺激技術の絶え間ない進歩が、電気治療薬の技術革新を促進しています。デバイスの小型化、バッテリー寿命の向上、ワイヤレス機能の強化により、多様な医療専門分野にわたって生体電気医学の適用性と採用が拡大しています。National Institute of Biomedical Imaging and Bioengineering（NIBIB）は、2020年から2023年の間にバイオエレクトロニクス医療研究のための資金が40%増加すると報告しています。

ヘルスケア支出の増加：

世界のヘルスケア支出の増加は、費用対効果の高い治療オプションの必要性と相まって、電気治療の採用を後押ししています。これらのデバイスは、治療効果を長期間持続させ、慢性疾患に関連する入院を最小限に抑えることで、長期的なヘルスケアコストを削減できる可能性があります。メディケア＆メディケイド・サービスセンター（CMS）の報告によると、米国のヘルスケア支出は2023年に4兆3,000億米ドルに達し、年間成長率は5.4％です。

認識と受容の高まり：

バイオエレクトリック療法の利点に対する医療従事者や患者の意識の高まりが、市場の受容を促進しています。臨床試験や患者の治療成績が良好なことから、電気製剤は実行可能な治療オプションであるとの信頼が高まり、市場の成長と普及がさらに加速しています。FDAは、2020年から2023年の間に電気治療機器の市販前承認が35%増加すると報告しています。

主な課題

規制上の課題：

医療機器の厳しい規制要件と長い承認プロセスが、生体電気医療分野における市場参入と製品商業化の障壁となる可能性があります。

限られた臨床証拠：

電気治療の安全性、有効性、長期的利益を実証するための確固たる臨床エビデンスの必要性は依然として課題です。データが不十分であったり、臨床結果がまちまちであったりすると、ヘルスケア提供者や患者による採用が妨げられる可能性があります。

高いコストと手頃な価格：

開発、製造、保守を含む電気治療機器に関連する高コストは、特に医療予算に制約のある地域では、市場の成長とアクセシビリティを制限する可能性があります。

技術の複雑さ：

デバイスの埋め込み、プログラミング、メンテナンスを含む生体電気医療技術の複雑さは、ヘルスケア専門家に専門的なトレーニングを必要とし、普及と患者の受容に課題をもたらす可能性があります。

競合情勢：

エレクトロシューティカルズ市場における既存医療機器企業と新興新興企業間の激しい競争は、価格圧力、技術革新の障壁、統合につながり、市場力学と収益性に影響を与える可能性があります。

主要動向

個別化医療：

診断学、遺伝学、データ解析の進歩を活用して治療成果を最適化し、個々の患者のプロファイルに合わせた個別化電気製剤治療を目指す傾向が強まっています。米国国立衛生研究所（NIH）によると、精密医療研究のための資金は2020年から2023年の間に35%増加し、2023年には18億米ドルに達します。

ワイヤレスとウェアラブル技術：

ワイヤレス通信とウェアラブル技術を電気製剤に統合することで、遠隔モニタリング、リアルタイムのデータ収集、患者の関与が可能になり、治療効果と患者の利便性が向上します。米国疾病予防管理センター（CDC）の2023年の報告書によると、慢性疾患を持つ成人の45%が何らかのウェアラブル医療技術を使用しており、2020年の32%から増加しています。

新たな治療領域への拡大：

生体電気医療は、疼痛管理や神経障害といった従来の用途にとどまらず、心臓病学、消化器病学、腫瘍学といった新たな治療分野へと拡大し、市場の可能性を広げています。2024年2月、エレクトロコアは胃食道逆流症（GERD）治療用の非侵襲的迷走神経刺激療法でFDAの認可を取得し、消化器内科市場に参入しました。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 エレクトロシューティカルズ・バイオエレクトリック医療市場：製品タイプ別

• 埋め込み型電気治療器
• 非侵襲性電気治療デバイス

第5章 エレクトロシューティカルズ・バイオエレクトリック医療市場：用途別

• 疼痛管理
• 神経疾患
• 心臓疾患
• 消化器疾患

第6章 エレクトロシューティカルズ・バイオエレクトリック医療市場：流通チャネル別

• 病院および診療所
• 外来手術センター
• 研究機関

第7章 地域別分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories, Inc.
• LivaNova PLC
• Cochlear Ltd.
• Axonics Modulation Technologies, Inc.
• Neuronetics, Inc.
• Second Sight Medical Products, Inc.
• NeuroPace, Inc.
• BIOTRONIK SE & Co. KG

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Electroceuticals Bioelectric Medicine Market Size And Forecast

Electroceuticals Bioelectric Medicine Market size was valued at USD 19.38 Billion in 2024 and is projected to reach USD 27.56 Billion by 2031, growing at a CAGR of 4.5% from 2024 to 2031. Electroceuticals, or bioelectric medicine, are medical devices that use electrical impulses to modulate neural circuits in the body to treat diseases. They target specific nerves or tissues, restoring physiological function or alleviating symptoms by altering electrical signals in the nervous system. Electroceuticals have diverse applications across various medical fields. They are commonly used in the treatment of chronic pain, neurological disorders, and metabolic conditions such as diabetes. For example, implantable neurostimulators can be used to manage chronic pain by blocking pain signals to the brain.

In neurology, deep brain stimulation (DBS) is employed to treat movement disorders like Parkinson's disease by modulating abnormal brain activity.

Additionally, electroceuticals show promise in applications such as cardiac pacing to regulate heart rhythms and bioelectronic implants to control insulin release in diabetes management.

The future of electroceuticals holds significant potential for innovation and expansion. Advancements in miniaturization, wireless technology, and biocompatible materials are enhancing the effectiveness and safety of electroceutical devices. Researchers are exploring new applications in areas such as mental health disorders, autoimmune diseases, and gastrointestinal disorders.

Global Electroceuticals Bioelectric Medicine Market Dynamics

The key market dynamics that are shaping the global electroceuticals bioelectric medicine market include:

Key Market Drivers

Increasing Demand for Non-pharmacological Therapies:

There is a growing preference among patients and healthcare providers for non-pharmacological treatments due to concerns over drug side effects and dependency. Electroceuticals offer targeted, precise therapies that can effectively manage conditions such as chronic pain, neurological disorders, and cardiovascular diseases. According to the National Center for Complementary and Integrative Health (NCCIH), a division of the NIH, the use of non-pharmacological pain management techniques increased by 25% between 2020 and 2023.

Technological Advancements:

Continuous advancements in electronics, materials science, and neurostimulation techniques are driving innovation in electroceuticals. Miniaturization of devices, improved battery life, and enhanced wireless capabilities are expanding the applicability and adoption of bioelectric medicine across diverse medical specialties. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) reported a 40% increase in funding for bioelectronic medicine research between 2020 and 2023.

Rising Healthcare Expenditure:

Increasing healthcare expenditure globally, coupled with the need for cost-effective treatment options, is boosting the adoption of electroceuticals. These devices can potentially reduce long-term healthcare costs by offering long-lasting therapeutic benefits and minimizing hospitalizations related to chronic conditions. The Centers for Medicare & Medicaid Services (CMS) reported that U.S. healthcare spending reached $4.3 trillion in 2023, with a 5.4% annual growth rate.

Growing Awareness and Acceptance:

Rising awareness among healthcare professionals and patients about the benefits of bioelectric therapies is driving market acceptance. Clinical studies and successful patient outcomes are increasing confidence in electroceuticals as viable treatment options, further accelerating market growth and adoption. The FDA reported a 35% increase in premarket approvals for electroceutical devices between 2020 and 2023.

Key Challenges:

Regulatory Challenges:

Stringent regulatory requirements and lengthy approval processes for medical devices can pose barriers to market entry and product commercialization in the bioelectric medicine sector.

Limited Clinical Evidence:

The need for robust clinical evidence to demonstrate safety, efficacy, and long-term benefits of electroceutical therapies remains a challenge. Insufficient data or mixed clinical outcomes may hinder adoption by healthcare providers and patients.

High Costs and Affordability:

The high costs associated with electroceutical devices, including development, manufacturing, and maintenance, can limit market growth and accessibility, particularly in regions with constrained healthcare budgets.

Technological Complexity:

The complexity of bioelectric medicine technologies, including device implantation, programming, and maintenance, requires specialized training for healthcare professionals and may pose challenges in widespread adoption and patient acceptance.

Competitive Landscape:

Intense competition among established medical device companies and emerging startups in the electroceuticals market can lead to pricing pressures, innovation barriers, and consolidation, impacting market dynamics and profitability.

Key Trends

Personalized Medicine:

There is a growing trend towards personalized electroceutical therapies tailored to individual patient profiles, leveraging advancements in diagnostics, genetics, and data analytics to optimize treatment outcomes. According to the National Institutes of Health (NIH), funding for precision medicine research increased by 35% between 2020 and 2023, reaching $1.8 billion in 2023.

Wireless and Wearable Technologies:

Integration of wireless communication and wearable technologies in electroceuticals allows for remote monitoring, real-time data collection, and patient engagement, enhancing treatment efficacy and patient convenience. A 2023 report from the Centers for Disease Control and Prevention (CDC) found that 45% of adults with chronic conditions used some form of wearable health technology, up from 32% in 2020.

Expansion into New Therapeutic Areas:

Bioelectric medicine is expanding beyond traditional applications like pain management and neurological disorders into new therapeutic areas such as cardiology, gastroenterology, and oncology, broadening its market potential. In February 2024, electroCore received FDA clearance for its non-invasive vagus nerve stimulation therapy to treat gastroesophageal reflux disease (GERD), marking its entry into the gastroenterology market.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Electroceuticals Bioelectric Medicine Market Regional Analysis

Here is a more detailed regional analysis of the global electroceuticals bioelectric medicine market:

North America

North America dominating the electroceuticals market due to several key factors. The region benefits from a robust healthcare infrastructure that facilitates adoption of advanced medical technologies. The American Hospital Association's 2023 annual survey revealed that 68% of U.S. hospitals had implemented at least one form of electroceutical therapy, up from 52% in 2020.

Technological advancements in neurostimulation and cardiac therapies are particularly prominent, supported by substantial healthcare expenditure and a proactive regulatory environment that fosters innovation. The National Institutes of Health (NIH) allocated USD 985 Million to neurotechnology research in fiscal year 2023, a 15% increase from 2021.

Strong research and development activities further enhance North America's position, driving continuous advancement and application of bioelectric medicine in clinical settings. The National Science Foundation reported that private sector R&D investment in medical equipment and supplies, including electroceuticals, reached USD 21.8 Billion in 2023, a 9.5% increase from 2021.

Asia Pacific

Asia Pacific is indeed emerging as a rapidly growing market for electroceuticals. The region's growth is fueled by increasing investments in healthcare infrastructure and technology, driven by countries such as China, Japan, and India. According to the World Health Organization (WHO), healthcare spending in the Asia Pacific region increased by an average of 7.2% annually between 2020 and 2023.

These nations are experiencing a rising prevalence of chronic diseases and expanding medical tourism, which further boosts demand for advanced medical treatments, including neuromodulation and cardiac devices. India's Ministry of Tourism reported that medical visa arrivals increased by 32% in 2023 compared to 2021, with neurology and cardiology being among the top specialties sought by international patients.

This trend underscores Asia Pacific's evolving role as a key player in the global electroceuticals market, supported by efforts to enhance healthcare access and technological capabilities. The China National Medical Products Administration (NMPA) approved 28 new electroceutical devices in 2023, compared to 18 in 2021, indicating accelerated innovation and regulatory support.

Global Electroceuticals Bioelectric Medicine Market: Segmentation Analysis

The Global Electroceuticals Bioelectric Medicine Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Electroceuticals Bioelectric Medicine Market, By Application

• Pain Management
• Neurological Disorders
• Cardiac Disorders
• Gastrointestinal Disorders

Based on Application, the Global Electroceuticals Bioelectric Medicine Market is bifurcated into Pain Management, Neurological Disorders, Cardiac Disorders, and Gastrointestinal Disorders. In the electroceuticals bioelectric medicine market, neurological disorders currently dominate as the leading application segment. This dominance is driven by the widespread adoption of neurostimulation therapies for conditions such as Parkinson's disease, epilepsy, and chronic pain syndromes. Neurological disorders benefit significantly from the precise targeting and modulation of neural circuits offered by bioelectric medicine, enhancing patient outcomes and quality of life. The Cardiac Disorders segment is rapidly growing, fueled by advancements in cardiac neuromodulation techniques and devices aimed at managing arrhythmias, heart failure, and other cardiovascular conditions.

Electroceuticals Bioelectric Medicine Market, By Product Type

• Implantable Electroceutical Devices
• Non-invasive Electroceutical Devices

Based on Product Type, the Global Electroceuticals Bioelectric Medicine Market is bifurcated into Implantable Electroceutical Devices and Non-invasive Electroceutical Devices. In the market, implantable electroceutical devices currently dominate as the leading product type segment. These devices, such as neurostimulators and implantable cardiac devices, offer targeted therapy directly at the site of action within the body, providing long-term management of chronic conditions like Parkinson's disease and cardiac arrhythmias. The precision and effectiveness of implantable devices contribute to their widespread adoption and market dominance. The Non-invasive Electroceutical Devices segment is rapidly growing, driven by advancements in technologies like transcutaneous electrical nerve stimulation (TENS) and external neuromodulation devices.

Electroceuticals Bioelectric Medicine Market, By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Research Institutes

Based on End-User, the Global Electroceuticals Bioelectric Medicine Market is bifurcated into Hospitals and Clinics, Ambulatory Surgical Centers, Research Institutes. In the electroceuticals bioelectric medicine market, hospitals and clinics is expected to dominate the leading end-user segment. Hospitals and clinics are primary settings for the diagnosis, treatment, and management of chronic conditions that benefit from bioelectric therapies, such as neurological disorders and cardiac diseases. These healthcare facilities have the infrastructure and expertise to support the use of electroceutical devices, driving their widespread adoption and market dominance. The Ambulatory Surgical Centers segment is rapidly growing, fueled by the increasing trend towards outpatient procedures and minimally invasive treatments using electroceutical devices.

Electroceuticals Bioelectric Medicine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Electroceuticals Bioelectric Medicine Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the market, North America is anticipated to lead geographical segment. This region benefits from a mature healthcare infrastructure, significant investments in research and development, and a proactive regulatory environment that supports the adoption of bioelectric medicine. North America's dominance is further bolstered by high healthcare expenditure and robust market penetration of advanced neurostimulation and cardiac devices. Asia Pacific is rapidly growing in the electroceuticals market, driven by increasing healthcare investments, rising prevalence of chronic diseases, and expanding adoption of advanced medical technologies.

Key Players

• The "Global Electroceuticals Bioelectric Medicine Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
• Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Inc., LivaNova PLC, Cochlear Ltd., Neuronetics, Inc., Second Sight Medical Products, Inc., NeuroPace, Inc., and BIOTRONIK SE & Co. KG.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Electroceuticals Bioelectric Medicine Market Key Developments

• In March 2024, Medtronic announced the FDA approval of its next-generation closed-loop deep brain stimulation system for Parkinson's disease. The system features adaptive stimulation based on real-time brain signals, marking a significant advancement in personalized neuromodulation therapy.
• In January 2024, Boston Scientific launched a new spinal cord stimulation platform with advanced pain targeting algorithms. The system incorporates AI-driven technology to optimize stimulation parameters based on individual patient responses, enhancing treatment efficacy for chronic pain conditions.
• In November 2023, Abbott Laboratories introduced a wireless neuromodulation system for chronic pain management. The device allows patients to control and monitor their therapy via a smartphone app, improving patient engagement and treatment adherence.
• In September 2023, Nevro Corp. received FDA approval for an expanded indication of its high-frequency spinal cord stimulation therapy to include treatment of painful diabetic neuropathy. This approval opens up a significant new market for the company's electroceutical technology.
• In July 2023, electroCore secured FDA clearance for its non-invasive vagus nerve stimulation therapy to treat gastroesophageal reflux disease (GERD). This marks the company's entry into the gastroenterology market, broadening the application of bioelectric medicine beyond its traditional domains.
• In April 2023, SetPoint Medical initiated a Phase II clinical trial for its bioelectronic therapy in treating inflammatory bowel disease. This development represents a significant step in expanding the application of electroceuticals to autoimmune disorders beyond rheumatoid arthritis.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Electroceuticals Bioelectric Medicine Market, By Product Type

• Implantable Electroceutical Devices
• Non-invasive Electroceutical Devices

5. Electroceuticals Bioelectric Medicine Market, By Application

• Pain Management
• Neurological Disorders
• Cardiac Disorders
• Gastrointestinal Disorders

6. Electroceuticals Bioelectric Medicine Market, By Distribution Channel

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Research Institutes

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories, Inc.
• LivaNova PLC
• Cochlear Ltd.
• Axonics Modulation Technologies, Inc.
• Neuronetics, Inc.
• Second Sight Medical Products, Inc.
• NeuroPace, Inc.
• BIOTRONIK SE & Co. KG

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References